GILEAD SCIENCES has a total of 88 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 1989. It filed its patents most often in Serbia, Croatia and Taiwan. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and biotechnology are GILEAD SCIENCE INC, BIOMARIN PHARM INC and GILEAD SCIENCES INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | Serbia | 15 | |
#2 | Croatia | 14 | |
#3 | Taiwan | 13 | |
#4 | Poland | 12 | |
#5 | United States | 6 | |
#6 | Australia | 4 | |
#7 | China | 3 | |
#8 | Cuba | 3 | |
#9 | Czechia | 3 | |
#10 | Hungary | 3 | |
#11 | Netherlands | 3 | |
#12 | Ireland | 2 | |
#13 | WIPO (World Intellectual Property Organization) | 2 | |
#14 | South Africa | 2 | |
#15 | Bulgaria | 1 | |
#16 | Canada | 1 | |
#17 | Israel | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Biotechnology | |
#4 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Special acyclic compounds | |
#5 | Sugars | |
#6 | Microorganisms | |
#7 | Measuring microorganism processes | |
#8 | Analysing materials | |
#9 | Peptides | |
#10 | Combinatorial chemistry |
# | Name | Total Patents |
---|---|---|
#1 | Kim Choung U | 14 |
#2 | Xu Lianhong | 11 |
#3 | Lee William A | 9 |
#4 | Liu Hongtao | 9 |
#5 | He Gong-Xin | 9 |
#6 | Desai Manoj C | 9 |
#7 | Mackman Richard L | 8 |
#8 | Chen Xiaowu | 7 |
#9 | Ray Adrian S | 6 |
#10 | Rohloff John C | 6 |
Publication | Filing date | Title |
---|---|---|
TW201728582A | Crystalline form | |
TW201725044A | Combination of a BTK inhibitor and a checkpoint inhibitor for treating cancers | |
TW201307288A | Compounds for the treatment of addiction | |
CN101336107A | Methods for improving the pharmacokinetics of HIV integrase inhibitors | |
PL404940A1 | Phosphonate analogues of HIV inhibitor compounds | |
ZA9806614B | Nucleotide analog composition | |
CN1139455A | Thrombin mutants | |
CA2092002A1 | Modified internucleoside linkages | |
US5264564A | Oligonucleotide analogs with novel linkages | |
US5399676A | Oligonucleotides with inverted polarity | |
US5164491A | Large scale synthesis of oligonucleotides and their associated analogs |